ABGENOMICS
AbGenomics develops targeted antibody therapeutics for the treatment of cancer and immune-related inflammatory diseases.
ABGENOMICS
Industry:
Biopharma Biotechnology Pharmaceutical Sales
Founded:
2000-01-01
Address:
Los Altos, California, United States
Country:
United States
Website Url:
http://www.abgenomics.com
Total Employee:
11+
Status:
Active
Contact:
+1 650 988 9912
Official Site Inspections
http://www.abgenomics.com
- Host name: 199.59.243.228
- IP address: 199.59.243.228
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Abgenomics"
AltruBio - Crunchbase Company Profile & Funding
With its R&D foundation in Taipei Taiwan since June 2000, AbGenomics has been focusing on the discovery and development of novel therapeutics for …See details»
abgenomics Company Profile | Management and Employees List
Abgenomics Profile and History AbGenomics International Inc., incorporated in Delaware with principal office in SFO Bay Area California, is a biopharmaceutical company integrated …See details»
Abgenomics - Genomics.org
Founded by a group of leading biomedical scientists in June 2000, AbGenomics Corporation is a biopharmaceutical company focusing on the discovery and development of novel therapeutic …See details»
AbGenomics International Inc. Information - RocketReach
AbGenomics International Inc. (AbG), incorporated in Delaware in 2006 with its principal office in San Francisco Bay Area, California, is a clinical stage biopharmaceutical company. …See details»
AltruBio Company Profile - Office Locations, Competitors ... - Craft
AltruBio (formerly AbGenomics) is a biopharmaceutical company focused on developing antibody therapeutics for the treatment of cancer and immune-related inflammatory diseases. It builds a …See details»
AltruBio
AbGenomics Holding Inc. Announces Company Name Change to AltruBio Inc. 2019 . 12 . 06 . The Business Journals─Bayer site head in Berkeley jumps to Peninsula cancer drug …See details»
abgenomics - Overview, News & Similar companies | ZoomInfo.com
AbGenomics International Inc., incorporated in Delaware with principal office in SFO Bay Area California, is a biopharmaceutical company integrated globally and virtually to develop …See details»
AbGenomics | IT History Society
AbGenomics is focused on developing targeted antibody therapeutics for the treatment of cancer and immune related inflammatory diseases.AbGenomics International Inc., incorporated in …See details»
AbGenomics International Inc - Company Profile and News
AbGenomics International Inc. develops therapeutics for cancer. The Company develops and markets targeted antibody therapeutics for the treatment of cancer and immune related …See details»
AbGenomics Holding Inc. Announces Company Name Change to …
On June 15, 2020 AbGenomics Holding Inc., a clinical stage biotech company, announced today that the company will be operating under a new name, AltruBio Inc., effective immediately …See details»
Abgenomics International Inc. - Drug pipelines, Patents ... - Patsnap
Explore Abgenomics International Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, and 1 literature.See details»
New name, new board, new focus: AltruBio relaunches with $63M …
Apr 15, 2021 Formerly known as AbGenomics Holding Inc., AltruBio's two antibody-targeted therapies are under development in six disease areas. Neihulizumab is the leading candidate, …See details»
AbGenomics International - VentureRadar
Find out more about AbGenomics International, Antibodies, Biologics and Antibody Therapeutics. All; Ranked; Organisation Names; Apps and Links. Homepage (myVR) Funding Deals Hub; …See details»
AltruBio
A non-profit organization focused on educating, supporting and empowering patients as well as their caregivers through patient-centered education and advocacy programs. American …See details»
Abgenomics - Genoreport.co.kr
Founded by a group of leading biomedical scientists in June 2000, AbGenomics Corporation is a biopharmaceutical company focusing on the discovery and development of novel therapeutic …See details»
AbGenomics International, Inc. - Drug pipelines, Patents, Clinical ...
Drugs associated with AbGenomics International, Inc. Leiolizumab. Target. PSGL-1. Mechanism. PSGL-1 agonists [+2] Active Org. AbGenomics International, Inc. [+1] Originator Org. ... The …See details»
AltruBio secures up to $225M after pivot to immune drug research
Jun 27, 2024 Biotechnology startup AltruBio recently secured a Series B funding round which could provide up to $225 million, continuing to benefit from a strategic shift made four years …See details»
AltruBio
Phase I Promising phase 2a results have been obtained with ALTB-168. With the same binding domains present on ALTB-268, phase 2a study of PsA of ALTB-268 is under planning.See details»
Abgenomics International Revenue, Growth & Competitor Profile
Nov 4, 2024 Abgenomics International's annual revenues are Less than $1 million (see exact revenue data) What industry is the company in? Abgenomics International is classified as …See details»
Pro-Stacey Abrams groups fined $300,000 after admitting they …
11 hours ago The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, …See details»